Results 31 to 40 of about 3,730 (177)

PERFIL DOS PACIENTES COM CÂNCER NO SANGUE QUE BUSCAM PELO SERVIÇO DA PSICOLOGIA DE UMA ASSOCIAÇÃO SOCIAL ESPECIALIZADA DE SÃO PAULO - RELATO DE EXPERIÊNCIA

Hematology, Transfusion and Cell Therapy
Introdução: O contexto oncológico traz a necessidade de uma assistência multiprofissional e diversas intervenções de cuidado em toda a jornada de tratamento, Esta jornada,em específico do câncer no sangue, afeta as bases de segurança.
LT Ferri, RC Pires
doaj   +1 more source

Assessing patient perspectives on enrollment in lymphoma clinical trials

Cancer, Volume 132, Issue 8, 15 April 2026.
Abstract Background Clinical trials drive advances in lymphoma care, yet certain patient groups including socioeconomically disadvantaged, racial/ethnic groups, and women remain underrepresented. Given limited/inconsistent data regarding solutions to improve clinical trial enrollment of these groups, the authors performed a study to assess patient ...
Neha Akkad, Minxing Chen, Sophia Nguyen, Alexis Romero, Lynne Nguyen, Lorna H. McNeill, Loretta J. Nastoupil, Jason Westin, Paolo Strati, Sairah Ahmed, Liliana Vallejo, Rebeca Yzquierdo, Amy Ayers, Christopher R. Flowers, Chijioke Nze   +14 more
wiley   +1 more source

Leucemia mielóide crônica e síndrome de hiper-viscosidade: relato de caso Chronicle myeloid leukemia and hiperviscosity syndrome: case report

Revista Brasileira de Terapia Intensiva, 2008
JUSTIFICATIVA E OBJETIVOS: A hiperleucocitose (> 100 x 10(9)/L) em leucemia mielóide crônica não é uma apresentação comum e pode determinar manifestações clínicas de hiper-viscosidade.
Juliana Amâncio, Gisele Scuro, Fernanda Martins Gazoni, Hélio Penna Guimarães, Letícia Sandre Vendrame, Renato Delascio Lopes, Antônio Carlos Lopes   +6 more
doaj   +1 more source

Aggressive prostate cancer is associated with pericyte dysfunction

Molecular Oncology, Volume 20, Issue 4, Page 947-961, April 2026.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero, Ane Martinez‐Larrinaga, Joaquim Grego‐Bessa, Saioa Garcia‐Longarte, Hielke van Splunder, Ianire Astobiza, Amaia Ercilla, Laura Bozal‐Basterra, Isabel Mendizabal, Pilar Villacampa, Arkaitz Carracedo, Mariona Graupera   +11 more
wiley   +1 more source

Preinfusion risk factors for the development of severe neurotoxicity following CART therapy in pediatric patients

HemaSphere, Volume 10, Issue 4, April 2026.
Abstract Neurotoxicity is a common and potentially life‐threatening complication after chimeric antigen receptor T‐cell therapy (CART) for pediatric B‐cell acute lymphoblastic leukemia (B‐ALL). The only consistently demonstrated clinical risk factor for severe neurotoxicity in prior studies is high, preinfusion bone marrow disease burden (DB).
Caroline Diorio, Regina M. Myers, Yimei Li, Hongyan Liu, Samuel Belfer, Amanda DiNofia, Allison Barz Leahy, Haley Newman, Jillian Dolan, Zachary Martinez, Amira Elhachimi, Robert B. Lindell, Cassidy Mullen, Alexander Li, John Kim, David T. Teachey, Shannon L. Maude, Stephan A. Grupp, Jennifer L. McGuire   +18 more
wiley   +1 more source

Análisis de los factores biopsicosocial que inciden en los pacientes diagnosticados con leucemia en la etapa infantil

Journal of the Academy, 2020
En el individuo existe factores biopsicosocial o dimensiones como el contexto escolar, familiar y anímico los cuales cambian de manera radical a causa de una enfermedad crónica como la leucemia, desencadenando daños colaterales en la familia y en el ...
Diana Carolina Pimiento Idiarte, Marisela Jaramillo López, Emely Campoverde Chamorro, Magi Pinduisaca Carrasco   +3 more
doaj   +1 more source

Increased risk of secondary malignancies after autologous transplantation in R/R follicular lymphoma: Long‐term results from FIL‐FLAZ12 Phase III trial

HemaSphere, Volume 10, Issue 8, August 2026.
Rita Tavarozzi, Andrea Evangelista, Manuela Zanni, Chiara Consoli, Alessandra Tucci, Barbara Botto, Silvia Bolis, Pietro Lauzzana, Vittorio Ruggero Zilioli, Benedetta Puccini, Annalisa Arcari, Vincenzo Pavone, Gloria Margiotta‐Casaluci, Monica Tani, Federica Cavallo, Antonio Pinto, Chiara Ghiggi, Domenico Pastore, Paolo Corradini, Andrés José María Ferreri, Angelo Palmas, Caterina Patti, Francesca Re, Fabio Benedetti, Giuseppe Milone, Stefano Luminari, Elsa Pennese, Elisa Bossi, Carola Boccomini, Antonella Anastasia, Chiara Bottelli, Donato Mannina, Samantha Pozzi, Catello Califano, Luca Arcaini, Flavio Falcinelli, Giuseppe Pietrantuono, Ilaria Del Giudice, Sara Usai, Jacopo Olivieri, Filippo Gherlinzoni, Attilio Olivieri, Tommasina Perrone, Fabrizio Pomponi, Giovannino Ciccone, Umberto Vitolo, Marco Ladetto   +46 more
wiley   +1 more source

Evidence and Equity Gaps in Clinical Care of Chronic Lymphocytic Leukaemia in Portugal: A Real‐World, Multicentre, Cohort Study

eJHaem, Volume 7, Issue 2, April 2026.
ABSTRACT Objectives Targeted therapies have markedly improved outcomes in chronic lymphocytic leukaemia (CLL), particularly among patients with TP53 alterations and unmutated IGHV. However, real‐world studies report persistent inequalities in access to optimal care.
Susana Esteves, Inês Coelho, José Carda, Sara Duarte, Inês Carvalhais, Daniela Alves, Rita Coutinho, Maria Gomes da Silva   +7 more
wiley   +1 more source

Epigenetic reprogramming in multiple myeloma—Challenges and opportunities

International Journal of Cancer, Volume 158, Issue 2, Page 423-432, 15 January 2026.
Abstract In cancer, mutational processes act in concert with epigenetic reprogramming to endow malignant cells with hallmark properties that underpin tumorigenesis. Compared with the relatively rigid and slow processes of genetic evolution, the plastic nature of chromatin enables cells to adapt to a changing environment more rapidly.
Subhasree Kumar, Lev M. Kats, Emily Gruber   +2 more
wiley   +1 more source

Leucemia cutis

Revista de la Asociación Colombiana de Dermatología y Cirugía Dermatológica, 2001
La leucemia cutis resulta de la infiltración de la epidermis, la dermis, y/o la grasa subcutánea por leucocitos neoplásicos o sus precursores, y puede tener diferentes apariencias y presentaciones, muchas de las cuales son similares a aquellas de los linfomas cutáneos.
Claudia Vélez Campuzano, Elina Bedoya Betancur, Juan Carlos Wolff Idárraga, Luis Alfonso Correa Londoño   +3 more
openaire   +1 more source